Status:
RECRUITING
GISAR German Interdisciplinary Sarcoma Registry
Lead Sponsor:
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Conditions:
Sarcoma
Sarcoma,Soft Tissue
Eligibility:
All Genders
18+ years
Brief Summary
GISAR has an open and modular setup. It is sought to include as many German sarcoma and CS patients (i.e. sarcoma and CS patients treated in Germany) in the registry as possible. A basic data set shou...
Detailed Description
Sarcomas are rare malignant tumors that affect people of all ages. They can be divided into different subtypes yet having more than 80 different forms of soft tissue sarcomas only. In these terms, it ...
Eligibility Criteria
Inclusion
- Histological verified bone or soft tissue sarcomas including bone and soft tissue tumors with borderline histological results or with unclear histological dignity like giant cell tumors of the bone (GCTB), desmoid tumors, atypical lipomatous tumors etc. - independent of therapy form and therapy line - or Histological verified sarcomatoid carcinomas/ carcinosarcomas: tumors with histological, cytological, or molecular properties of both epithelial tumors ("carcinoma") and mesenchymal tumors ("sarcoma") - independent of therapy form and therapy line.
- Signed informed consent form or equivalent (s. chapter 10)
- Age ≥18 years
Exclusion
- none
Key Trial Info
Start Date :
November 29 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2038
Estimated Enrollment :
9000 Patients enrolled
Trial Details
Trial ID
NCT04122872
Start Date
November 29 2018
End Date
January 1 2038
Last Update
October 18 2024
Active Locations (21)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitätsklinikum Tübingen
Tübingen, Baden-Wurttemberg, Germany, 72076
2
Universitätsklinikum Erlangen
Erlangen, Bavaria, Germany, 91054
3
HELIOS Klinikum Bad Saarow
Bad Saarow, Germany
4
HELIOS Klinikum Berlin-Buch
Berlin, Germany